SANUWAVE Health, Inc. ( SNWV ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Morgan Frank - CEO & Chairman Peter Sorensen - CFO & Secretary Conference Call Participants Ian Cassel - Intelligent Fanatics Capital Management Llc Kyle Bauser - ROTH Capital Partners, LLC, Research Division Carl Byrnes - Northland Capital Markets, Research Division Alex Silverman - AWM Investment Company Inc Andrew Rem Presentation Operator Good day, everyone, and welcome to the SANUWAVE earnings call. [Operator Instructions] Please note, this call may be recorded.
Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q3 2025 Earnings Call October 6, 2025 5:30 PM EDT Company Participants Morgan Frank - CEO & Chairman Conference Call Participants Kyle Bauser - ROTH Capital Partners, LLC, Research Division Carl Byrnes - Northland Capital Markets, Research Division Presentation Operator Good day, everyone, and welcome to the SANUWAVE Q3 Revenue Update. [Operator Instructions] Please note today's call will be recorded.
| Health Care Technology Industry | Healthcare Sector | Morgan C. Frank CEO | NASDAQ (NMS) Exchange | 80303D107 CUSIP |
| US Country | 46 Employees | - Last Dividend | - Last Split | - IPO Date |
SANUWAVE Health, Inc. is at the forefront of the medical field with its innovative use of shock wave technology. This company is dedicated to the research, development, and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and various other applications both in the United States and internationally. Founded in 2004 and based in Eden Prairie, Minnesota, SANUWAVE aims to harness the power of these shockwaves to stimulate a biological response, encouraging the body to heal itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. By focusing on this niche, SANUWAVE Health, Inc. is leading the way in providing advanced solutions for regenerative healing and pain management.
This system is designed to treat diabetic foot ulcers and other chronic wounds. It employs SANUWAVE's proprietary pulsed acoustic cellular expression technology to accelerate the healing process, improving the body's natural regeneration of skin and tissue through noninvasive means. This approach provides a revolutionary way to tackle difficult-to-heal wounds, offering hope and healing to patients suffering from these chronic conditions.
Targeted at treating tendinopathies, acute, and nonunion fractures, the orthoPACE system uses shock wave technology to stimulate the healing process. It is especially useful in the orthopedic field, where it aids in the recovery of musculoskeletal injuries by enhancing the body's repair mechanisms. This system is valuable for athletes and individuals suffering from various orthopedic conditions, offering a noninvasive alternative to traditional treatments.
Developed to cater to needs in sports medicine and physical therapy, the Profile system is SANUWAVE Health's answer to pain management. By leveraging shock wave technology, it provides a solution that not only manages pain but also promotes the healing of musculoskeletal injuries. This makes it an essential tool for therapists and sports medicine professionals seeking effective and noninvasive treatment options for their patients.
This device represents a non-contact and non-thermal ultrasound therapy solution aimed at treating diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. UltraMIST stands out for providing a gentle yet effective treatment option that stimulates the body's natural healing processes without the need for invasive procedures. It is particularly beneficial for patients with wounds that are resistant to conventional therapies, offering a fresh approach to wound care and management.